Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yu-Hao Tang"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundStereotactic body radiation therapy (SBRT) has emerged as a novel intervention for early-stage hepatocellular carcinoma (HCC). The outcomes of SBRT, liver resection (LR), and radiofrequency ablation (RFA) as the initial treatment for AJCC s
Externí odkaz:
https://doaj.org/article/386aeff99344459ab9260bc340b942a1
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundLenvatinib combined with programmed cell death protein-1 (PD-1) inhibitors has resulted in good survival outcomes in the treatment of unresectable hepatocellular carcinoma (HCC). Hepatic artery infusion chemotherapy (HAIC) has also attracte
Externí odkaz:
https://doaj.org/article/a6a2777c0c4046618ba1ef41065e014a
Publikováno v:
IEEE Transactions on Circuits and Systems for Video Technology. 33:30-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72f726971284a618ab2b55264be676bc
https://doi.org/10.1109/tcsvt.2022.3197643
https://doi.org/10.1109/tcsvt.2022.3197643
Autor:
Zhong-Guo Zhou, Min-Shan Chen, Dong-Ming Kuang, Jiajie Hou, Yao-Jun Zhang, Li Xu, Anna Kan, Jian-Cong Chen, Rongxin Zhang, Yu-Hao Tang, Xue-Chao Liu, Yuan Wei, Jin-Bin Chen, Shi-Xun Lu, Dong-Ping Chen, Jun-Cheng Wang
Supplementary Figure from PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7d9cf595aa9a4413cda4807f712954
https://doi.org/10.1158/0008-5472.22431855.v1
https://doi.org/10.1158/0008-5472.22431855.v1
Autor:
Zhong-Guo Zhou, Min-Shan Chen, Dong-Ming Kuang, Jiajie Hou, Yao-Jun Zhang, Li Xu, Anna Kan, Jian-Cong Chen, Rongxin Zhang, Yu-Hao Tang, Xue-Chao Liu, Yuan Wei, Jin-Bin Chen, Shi-Xun Lu, Dong-Ping Chen, Jun-Cheng Wang
Cancer immunotherapy restores or enhances the effector function of T cells in the tumor microenvironment, but the efficacy of immunotherapy has been hindered by therapeutic resistance. Here, we identify the proto-oncogene serine/threonine protein kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d55969771aab08602f0dd0fe2d9df0
https://doi.org/10.1158/0008-5472.c.6514014
https://doi.org/10.1158/0008-5472.c.6514014
Autor:
Zhong-Guo Zhou, Min-Shan Chen, Dong-Ming Kuang, Jiajie Hou, Yao-Jun Zhang, Li Xu, Anna Kan, Jian-Cong Chen, Rongxin Zhang, Yu-Hao Tang, Xue-Chao Liu, Yuan Wei, Jin-Bin Chen, Shi-Xun Lu, Dong-Ping Chen, Jun-Cheng Wang
Supplementary Data from PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cfe6f0b35f2478d7e1a0f6dede43d7
https://doi.org/10.1158/0008-5472.22431861
https://doi.org/10.1158/0008-5472.22431861
Publikováno v:
Nonlinear Dynamics. 105:2539-2548
Under investigation in this paper is the Ivancevic option pricing model. Based on trial function method, rogue wave and dark wave solutions are constructed. By means of symbolic computation, these analytical solutions are obtained with the Maple. Per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::687543427b4416a677e85bd549f7d502
https://doi.org/10.1007/s11071-021-06642-6
https://doi.org/10.1007/s11071-021-06642-6
Autor:
Jun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu, Jin-Bin Chen, Yuan Wei, Xue-Chao Liu, Yu-Hao Tang, Rongxin Zhang, Jian-Cong Chen, Anna Kan, Li Xu, Yao-Jun Zhang, Jiajie Hou, Dong-Ming Kuang, Min-Shan Chen, Zhong-Guo Zhou
Publikováno v:
Cancer research. 82(18)
Cancer immunotherapy restores or enhances the effector function of T cells in the tumor microenvironment, but the efficacy of immunotherapy has been hindered by therapeutic resistance. Here, we identify the proto-oncogene serine/threonine protein kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef18b9c7e2b81dd48d478d0ac3dcc067
https://pubmed.ncbi.nlm.nih.gov/35802648
https://pubmed.ncbi.nlm.nih.gov/35802648
Publikováno v:
Frontiers in Oncology
Background Lenvatinib combined with programmed cell death protein-1 (PD-1) inhibitors has resulted in good survival outcomes in the treatment of unresectable hepatocellular carcinoma (HCC). Hepatic artery infusion chemotherapy (HAIC) has also attract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49608a8ac9ec0aa21199ecae2dd5c743
https://pubmed.ncbi.nlm.nih.gov/33718175
https://pubmed.ncbi.nlm.nih.gov/33718175